{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:40:59Z","timestamp":1773704459826,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.prostaglandins.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T18:34:46Z","timestamp":1496255686000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells"],"prefix":"10.1016","volume":"131","author":[{"given":"Tayebeh","family":"Ranjbarnejad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massoud","family":"Saidijam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirin","family":"Moradkhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rezvan","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prostaglandins.2017.05.003_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.05.003_bib0010","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/ijc.26251","article-title":"Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers","volume":"130","author":"Yadav","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.05.003_bib0015","doi-asserted-by":"crossref","first-page":"e63872","DOI":"10.1371\/journal.pone.0063872","article-title":"Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.prostaglandins.2017.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJM200006293422606","article-title":"Chemoprevention of colorectal cancer","volume":"342","author":"J\u00e4nne","year":"2000","journal-title":"New Engl. J. Med."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.05.003_bib0025","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1517\/13543784.17.9.1341","article-title":"Natural products as inhibitors of carcinogenesis","volume":"17","author":"Guilford","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.05.003_bib0030","first-page":"84","article-title":"Curcumin inhibits the proliferation of a human colorectal cancer cell line Caco-2 partially by both apoptosis and G2\/M cell cycle arrest","volume":"4","author":"Fujimoto","year":"2014","journal-title":"Int. J. Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.05.003_bib0035","doi-asserted-by":"crossref","first-page":"17279","DOI":"10.3390\/ijms140917279","article-title":"Potential targets for colorectal cancer prevention","volume":"14","author":"Temraz","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.05.003_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0304-3835(01)00655-3","article-title":"Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells","volume":"172","author":"Goel","year":"2001","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.05.003_bib0045","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/onc.2009.421","article-title":"The role of COX-2 in intestinal inflammation and colorectal cancer","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.05.003_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.05.003_bib0060","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3390\/ph3072007","article-title":"NSAIDs and cell proliferation in colorectal cancer","volume":"3","author":"Ettarh","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-7-79","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice","volume":"7","author":"Moore","year":"2006","journal-title":"BMC Musculoskelet. Disord."},{"issue":"904","key":"10.1016\/j.prostaglandins.2017.05.003_bib0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/pmj.77.904.82","article-title":"Non-steroidal anti-inflammatory drugs and gastrointestinal damage\u2014problems and solutions","volume":"77","author":"Russell","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.prostaglandins.2017.05.003_bib0075","article-title":"Garcinol exhibits anti-proliferative activities by targeting microsomal prostaglandin E synthase -1 in human colon cancer cells","author":"Ranjbarnejad","year":"2016","journal-title":"Hum. Exp. Toxicol."},{"issue":"15","key":"10.1016\/j.prostaglandins.2017.05.003_bib0080","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4155\/fmc.11.136","article-title":"Identification and development of mPGES-1 inhibitors: where we are at?","volume":"3","author":"Chang","year":"2011","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.05.003_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pr.59.3.1","article-title":"Membrane prostaglandin E synthase-1: a novel therapeutic target","volume":"59","author":"Samuelsson","year":"2007","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.05.003_bib0090","doi-asserted-by":"crossref","first-page":"e26943","DOI":"10.1371\/journal.pone.0026943","article-title":"Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets","volume":"6","author":"Park","year":"2011","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.prostaglandins.2017.05.003_bib0095","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1074\/jbc.M213290200","article-title":"Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis","volume":"278","author":"Kamei","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.05.003_bib0100","first-page":"208","article-title":"The PGE2-EP receptor axis in colorectal cancer and angiogenesis","volume":"2","author":"Tak","year":"2014","journal-title":"J. Tumor"},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.05.003_bib0105","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1172\/JCI22218","article-title":"Prostaglandin E 2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation","volume":"114","author":"Tessner","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.05.003_bib0110","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1248\/bpb.29.1976","article-title":"Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri","volume":"29","author":"Akihisa","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1476-5381.2010.01020.x","article-title":"Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense","volume":"162","author":"Siemoneit","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"6\u20138","key":"10.1016\/j.prostaglandins.2017.05.003_bib0120","first-page":"261","article-title":"Role of boswellic acids in cancer treatment","volume":"14","author":"Dureja","year":"2014","journal-title":"J. Med. Sci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.05.003_bib0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/carcin\/21.3.525","article-title":"Chemoprevention of cancer","volume":"21","author":"Sporn","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.prostaglandins.2017.05.003_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/749310","article-title":"Dietary agents in cancer chemoprevention and treatment","volume":"2012","author":"Raffoul","year":"2012","journal-title":"J. Oncol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.05.003_bib0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/003655201750313405","article-title":"Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon","volume":"36","author":"Khan","year":"2001","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.05.003_bib0140","first-page":"209","article-title":"Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients","volume":"3","author":"Frommel","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.05.003_bib0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ptr.3055","article-title":"Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilage","volume":"24","author":"Blain","year":"2010","journal-title":"Phytother. Res."},{"issue":"12","key":"10.1016\/j.prostaglandins.2017.05.003_bib0150","first-page":"3971","article-title":"Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer","volume":"7","author":"Yoshimatsu","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.05.003_bib0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ijc.11422","article-title":"Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines","volume":"107","author":"van Rees","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/carcin\/bgh302","article-title":"Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice","volume":"26","author":"Blaine","year":"2005","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.05.003_bib0165","first-page":"51","article-title":"Boswellia Serrata Suppresses Colorectal Carcinogenesis: In-vitro and In-vivo Studies","volume":"25","author":"Ahmed","year":"2014","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.05.003_bib0170","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1211\/jpp.61.10.0003","article-title":"Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials","volume":"61","author":"Moussaieff","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.05.003_bib0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1158\/1535-7163.MCT-03-0266","article-title":"Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells","volume":"4","author":"Xia","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0180","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.174.1.498","article-title":"Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-\u03b1 induction in monocytes by direct interaction with I\u03baB kinases","volume":"174","author":"Syrovets","year":"2005","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.05.003_bib0185","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1074\/jbc.M409477200","article-title":"Inhibition of I\u03baB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo","volume":"280","author":"Syrovets","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.05.003_bib0190","doi-asserted-by":"crossref","first-page":"G798","DOI":"10.1152\/ajpgi.00433.2004","article-title":"Effects of Boswellia serrata in mouse models of chemically induced colitis","volume":"288","author":"Kiela","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.05.003_bib0195","doi-asserted-by":"crossref","first-page":"e0125375","DOI":"10.1371\/journal.pone.0125375","article-title":"Boswellia serrata preserves intestinal epithelial barrier from oxidative and inflammatory damage","volume":"10","author":"Catanzaro","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.05.003_bib0200","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.176.5.3127","article-title":"Acetyl-11-keto-\u03b2-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-\u03baB and NF-\u03baB-regulated gene expression","volume":"176","author":"Takada","year":"2006","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.prostaglandins.2017.05.003_bib0205","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1016\/j.bmcl.2007.10.011","article-title":"Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids","volume":"17","author":"Shah","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0210","first-page":"247","article-title":"Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells","volume":"19","author":"Kuo","year":"2005","journal-title":"In Vivo"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.05.003_bib0215","first-page":"2012","article-title":"Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancer","volume":"5","author":"Jiang","year":"2015","journal-title":"Am. J. Cancer. Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/jcmm.12418","article-title":"Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell survival via \u03b2-catenin stabilization","volume":"19","author":"Jansen","year":"2015","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.05.003_bib0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.05.003_bib0230","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"18","key":"10.1016\/j.prostaglandins.2017.05.003_bib0235","first-page":"3964","article-title":"Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer","volume":"55","author":"Takahashi","year":"1995","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.05.003_bib0240","first-page":"199","article-title":"VEGF expression in pancreatic cancer and other malignancies: a review of the literature","volume":"53","author":"Costache","year":"2015","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.prostaglandins.2017.05.003_bib0245","series-title":"VEGF and Cancer","author":"Harmey","year":"2004"},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.05.003_bib0250","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/1440-1681.12590","article-title":"Cytoprotective effects of endothelin-1 on mesenchymal stem cells: an in vitro study","volume":"43","author":"Pourjafar","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.05.003_bib0255","first-page":"108","article-title":"PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system","volume":"27","author":"Ding","year":"2005","journal-title":"Exp. Oncol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.05.003_bib0260","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1006\/bbrc.2001.5494","article-title":"PGE 2 stimulates VEGF expression in endothelial cells via ERK2\/JNK1 signaling pathways","volume":"286","author":"Pai","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.05.003_bib0265","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mc.20320","article-title":"Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway","volume":"46","author":"Wang","year":"2007","journal-title":"Mol. Carcinog."},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.05.003_bib0270","first-page":"2330","article-title":"Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1","volume":"63","author":"Fukuda","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.05.003_bib0275","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10555-010-9235-2","article-title":"Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals","volume":"29","author":"Gupta","year":"2010","journal-title":"Cancer Metastasis Rev."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.05.003_bib0280","first-page":"1323","article-title":"Patterns of MMP-2 and MMP-9 expression in human cancer cell lines","volume":"21","author":"Roomi","year":"2009","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.05.003_bib0285","first-page":"2396","article-title":"Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer","volume":"7","author":"Schmalfeldt","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0290","first-page":"190","article-title":"Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer","volume":"56","author":"Liabakk","year":"1996","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.05.003_bib0295","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3736\/jcim20101110","article-title":"Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1","volume":"8","author":"Liang","year":"2010","journal-title":"Zhong xi yi jie he xue bao= J. Chin. Integr. Med."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.05.003_bib0300","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/jhep.2001.23002","article-title":"Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and-9 in fetal rat hepatocytes","volume":"33","author":"Callejas","year":"2001","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.prostaglandins.2017.05.003_bib0305","first-page":"2555","article-title":"Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression","volume":"60","author":"Murono","year":"2000","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.05.003_bib0310","first-page":"325","article-title":"Molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis","volume":"31","author":"Fosslien","year":"2001","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.prostaglandins.2017.05.003_bib0315","series-title":"Chemokines in the Recruitment and Shaping of the Leukocyte Infiltrate of Tumors, Seminars in Cancer Biology","first-page":"155","author":"Mantovani","year":"2004"},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.05.003_bib0320","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1349-7006.2007.00606.x","article-title":"Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response","volume":"98","author":"Koizumi","year":"2007","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.05.003_bib0325","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijc.25966","article-title":"Acetyl-11-keto-\u03b2-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression","volume":"129","author":"Park","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.05.003_bib0330","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2353\/ajpath.2010.090607","article-title":"COX-2 and prostaglandin EP3\/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems","volume":"176","author":"Katoh","year":"2010","journal-title":"Am. J. Pathol."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316301253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316301253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:38:44Z","timestamp":1659055124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882316301253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":66,"alternative-id":["S1098882316301253"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.05.003","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methanolic extract of Boswellia serrata exhibits anti-cancer activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}